Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors

被引：11

作者：

Szabo, Monika ^{[1
]}

Lim, Herman D. ^{[1
]}

Herenbrink, Carmen Klein ^{[1
]}

Christopoulos, Arthur ^{[1
]}

Lane, J. Robert ^{[1
]}

Capuano, Ben ^{[1
]}

机构：

[1] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2015年 / 58卷 / 03期

基金：

英国医学研究理事会;

关键词：

ALLOSTERIC MODULATORS; AGONIST; DRUGS; ANTIPSYCHOTICS; DISCOVERY; MODES; LEAD;

D O I：

10.1021/jm5013243

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Herein we describe the hybridization of a benzoxazinone M-1 scaffold with D-2 privileged structures derived from putative and clinically relevant antipsychotics to develop designed multiple ligands. The M-1 mAChR is an attractive target for the cognitive deficits in key CNS disorders. Moreover, activity at D-2 and 5-HT2A receptors has proven useful for antipsychotic efficacy. We identified 9 which retained functional activity at the target M-1 mAChR and D2R and demonstrated high affinity for the 5-HT2AR.

引用

页码：1550 / 1555

页数：6

共 50 条

[21] Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers
Escuela, D. O. Borroto
Fernandez, W. Romero
Tarakanov, A.
Alea, M. Perez
Ciruela, F.
Agnati, L.
Fuxe, K.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 159 - 159
[22] Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers
Borroto-Escuela, Dasiel O.
Romero-Fernandez, Wilber
Tarakanov, Alexander O.
Marcellino, Daniel
Ciruela, Francisco
Agnati, Luigi F.
Fuxe, Kjell
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 401 (04) : 605 - 610
[23] Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors
Zajdel, Pawel
Marciniec, Krzysztof
Maslankiewicz, Andrzej
Grychowska, Katarzyna
Satala, Grzegorz
Duszynska, Beata
Lenda, Tomasz
Siwek, Agata
Nowak, Gabriel
Partyka, Anna
Wrobel, Dagmara
Jastrzebska-Wiesek, Magdalena
Bojarski, Andrzej J.
Wesolowska, Anna
Pawlowski, Maciej
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 60 : 42 - 50
[24] THE EFFECT OF GYKI-32-887 ON DOPAMINE (D2) AND SEROTONIN (5-HT1 AND 5-HT2) RECEPTORS
BERZETEI, IP
BAGDY, E
HARDY, M
BORSY, J
POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (03): : 237 - 242
[25] Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors
Glennon, RA
Dukat, M
Grella, B
Hong, SS
Costantino, L
Teitler, M
Smith, C
Egan, C
Davis, K
Mattson, MV
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) : 121 - 132
[26] SEROTONIN 5-HT2A, DOPAMINE D2 AND NORADRENALINE ALPHA-1 ANTAGONISTS - ANALOGS OF THE ATYPICAL ANTIPSYCHOTIC SERTINDOLE
ANDERSEN, K
PERREGAARD, J
LILJEFORS, T
HYTTEL, J
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 130 - MEDI
[27] Dopamine/serotonin receptor ligands.: Part 17:: A cross-target SAR approach:: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors
Enzensperger, Christoph
Goernemann, Tilo
Pertz, Heinz H.
Lehmann, Jochen
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3809 - 3813
[28] Iloperidone -: Antipsychotic dopamine D2 antagonist 5-HT2A antagonist
不详
DRUGS OF THE FUTURE, 2001, 26 (01) : 80 - 80
[29] Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT2A and dopamine D2 receptors in rat prefrontal cortex
Franklin, Jade M.
Carrasco, Gonzalo A.
JOURNAL OF PSYCHOPHARMACOLOGY, 2012, 26 (10) : 1333 - 1347
[30] Modulation by Uncaria tomentosa alkaloids of 5-HT2 receptors and muscarinic M1 acetylcholine receptors expressed in Xenopus oocytes
Kang, TH
Matsumoto, K
Takayama, H
Kitajima, M
Aimi, N
Watanabe, H
JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 210P - 210P

← 1 2 3 4 5 →